Business Update & Appendix 4C
Filed with ASX · · 10 pages · English
Story so far
Earlier from Cogstate
- Cogstate Establishes Rare Disease and Pediatric Expertise
- S&P DJ Indices Announces March Quarterly Rebalance
- Appendix 4D & Half Year Financial Report
- Global Alzheimer Platform Foundation Selects Cogstate
- Interim Business Update
Later from Cogstate
- Cogstate announces European approval for Cognigram
- AD trial discontinued - limited CGS impact
- Full Year Financial Results Summary
- AGM Presentation
- Change of Director’s Interest Notice
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate